Global and China Point-of-Care (POC) Coagulation Testing Industry Ecological Development and Analysis Report 2023

Report ID: ARS1421 | Category: Healthcare | Pages: 99 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3100.00 Multi User-$5600.00

Report Description
View Table of Contents

Report Summary

In terms of market side, this report researches the Point-of-Care (POC) Coagulation Testing revenue, growth rate, market share by manufacturers, by type, by application and by region (region level and country level), from 2018 to 2023, and forecast to 2029.

The global Point-of-Care (POC) Coagulation Testing market size in 2022 is XX million US dollars, and it is expected to be 1953.4 million US dollars by 2029, with a compound annual growth rate of 4.61% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Point-of-Care (POC) Coagulation Testing market include Abbott (U.S.), Danaher (U.S.), Siemens (Germany), Sysmex Corporation (U.S.), and Thermo Fisher Scientific Inc.  (U.S.). The share of the top 3 players in the Point-of-Care (POC) Coagulation Testing market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Point-of-Care (POC) Coagulation Testing market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Optical Technology accounted for XX% of Point-of-Care (POC) Coagulation Testing market in 2022. Mechanical Technology share of XX%.
Hospitals accounted for XX% of the Point-of-Care (POC) Coagulation Testing market in 2022. Clinics accounts for XX%.

Report Includes:
This report presents an overview of global market for Point-of-Care (POC) Coagulation Testing. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key players of Point-of-Care (POC) Coagulation Testing, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Point-of-Care (POC) Coagulation Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Point-of-Care (POC) Coagulation Testing market share and industry ranking of main players, data from 2018 to 2023. Identification of the major stakeholders in the global Point-of-Care (POC) Coagulation Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, from 2018 to 2029. Evaluation and forecast the market size for Point-of-Care (POC) Coagulation Testing sales, projected growth trends, technology, application and end-user industry.

The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.

Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.

Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.

Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.

Highlights-Regions

North America
   United States
   Canada
China
Asia Pacific (Excluding China)
   Japan
   Korea
   Southeast Asia
   India
   Australia
EMEA
Europe
   Germany
   France
   UK
   Italy
   Russia
   Nordic
Middle East
Africa
Latin America
   Brazil
   Argentina
   Mexico

Player list
	Abbott (U.S.)
	Danaher (U.S.)
	Siemens (Germany)
	Sysmex Corporation (U.S.)
	Thermo Fisher Scientific Inc.  (U.S.)
	Horiba Ltd.  (Japan)
	Nihon Kohden Corporation (Japan)
	F. Hoffmann-La Roche Ltd (Switzerland)
	Maccura Biotechnology Co. Ltd. (China)
	Bio Group Medical System (Italy)
	Genrui Biotech Co. Ltd. (China)
	A&T Corporation (Japan)
	Beijing Succeeder Technology Inc. (China)
	Diagnostica Stago SAS (France)
	Helena Laboratories Corporation (U.S.)
	Hycel (Austria)

Types list
	Optical Technology
	Mechanical Technology
	Electrochemical Technology

Application list
	Hospitals
	Clinics
	Home care

Table of Content

1 Point-of-Care (POC) Coagulation Testing Market Introduction and Overview
1.1 Point-of-Care (POC) Coagulation Testing Definition
1.2 Research Purposes
1.3 Currency Rate
1.4 Report Timeline
1.5 Economic Analysis of Global Regions
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Point-of-Care (POC) Coagulation Testing Revenue and Market Share by Manufacturer
2.2 Manufacturers Point-of-Care (POC) Coagulation Testing Production Sites, Area Served, Product Types
2.3 Point-of-Care (POC) Coagulation Testing Market Competitive Situation and Trends
2.3.1 Point-of-Care (POC) Coagulation Testing Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
2.3.3 Mergers & Acquisitions, Expansion
3 Global Point-of-Care (POC) Coagulation Testing Historical Market Analysis by Type
3.1 Market Size Analysis by Types
3.1.4 Global Point-of-Care (POC) Coagulation Testing Market Share by Type 2018 VS 2022
3.2 Global Point-of-Care (POC) Coagulation Testing Revenue and Market Share by Type
4 Global Point-of-Care (POC) Coagulation Testing Historical and Forecast Market Analysis by Application
4.1 Market Size Analysis by Application
4.1.4 Global Point-of-Care (POC) Coagulation Testing Market Share by Application 2018 VS 2022
4.2 Global Point-of-Care (POC) Coagulation Testing Revenue Market Share by Application (2018-2023)
5 Global Market Growth Trends Analysis
5.1 Global Point-of-Care (POC) Coagulation Testing Market Size (2018-2023)
5.2 Point-of-Care (POC) Coagulation Testing Growth Trends Analysis by Regions
5.2.1 Point-of-Care (POC) Coagulation Testing Market Size by Regions: 2018 VS 2023 VS 2029
5.2.2 Point-of-Care (POC) Coagulation Testing Historic Revenue Market Size by Regions (2018-2023)
5.3 North America
5.3.1 North America Point-of-Care (POC) Coagulation Testing Revenue by Countries (2018-2023)
5.3.2 North America SWOT Analysis
5.3.3 United States
5.3.4 Canada
5.4 China
5.4.1 China SWOT Analysis
5.5 Asia Pacific (Excluding China)
5.5.1 Asia Pacific Point-of-Care (POC) Coagulation Testing Revenue by Countries (2018-2023)
5.5.2 Asia Pacific SWOT Analysis
5.5.3 Japan
5.5.4 Korea
5.5.5 Southeast Asia
5.5.6 India
5.5.7 Australia
5.6 EMEA
5.6.1 EMEA Point-of-Care (POC) Coagulation Testing Revenue by Countries (2018-2023)
5.6.2 EMEA SWOT Analysis
5.6.3 Europe
5.6.4 Middle East
5.6.5 Africa
5.7 Latin America
5.7.1 Latin America Point-of-Care (POC) Coagulation Testing Revenue by Countries (2018-2023)
5.7.2 Latin America SWOT Analysis
5.7.3 Brazil
5.7.4 Argentina
5.7.5 Mexico
6 Players Profiles
6.1  Abbott (U.S.)
6.1.1 Abbott (U.S.) Company Profile
6.1.2 Point-of-Care (POC) Coagulation Testing Product Overview
6.1.3 Abbott (U.S.) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
6.1.4 Abbott (U.S.) Business Overview
6.1.5 SWOT Analysis
6.2  Danaher (U.S.)
6.2.1 Danaher (U.S.) Company Profile
6.2.2 Point-of-Care (POC) Coagulation Testing Product Overview
6.2.3 Danaher (U.S.) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
6.2.4 Danaher (U.S.) Business Overview
6.2.5 SWOT Analysis
6.3  Siemens (Germany)
6.3.1 Siemens (Germany) Company Profile
6.3.2 Point-of-Care (POC) Coagulation Testing Product Overview
6.3.3 Siemens (Germany) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
6.3.4 Siemens (Germany) Business Overview
6.3.5 SWOT Analysis
6.4  Sysmex Corporation (U.S.)
6.4.1 Sysmex Corporation (U.S.) Company Profile
6.4.2 Point-of-Care (POC) Coagulation Testing Product Overview
6.4.3 Sysmex Corporation (U.S.) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
6.4.4 Sysmex Corporation (U.S.) Business Overview
6.4.5 SWOT Analysis
6.5  Thermo Fisher Scientific Inc.  (U.S.)
6.5.1 Thermo Fisher Scientific Inc.  (U.S.) Company Profile
6.5.2 Point-of-Care (POC) Coagulation Testing Product Overview
6.5.3 Thermo Fisher Scientific Inc.  (U.S.) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
6.5.4 Thermo Fisher Scientific Inc.  (U.S.) Business Overview
6.5.5 SWOT Analysis
6.6  Horiba Ltd.  (Japan)
6.6.1 Horiba Ltd.  (Japan) Company Profile
6.6.2 Point-of-Care (POC) Coagulation Testing Product Overview
6.6.3 Horiba Ltd.  (Japan) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
6.6.4 Horiba Ltd.  (Japan) Business Overview
6.6.5 SWOT Analysis
6.7  Nihon Kohden Corporation (Japan)
6.7.1 Nihon Kohden Corporation (Japan) Company Profile
6.7.2 Point-of-Care (POC) Coagulation Testing Product Overview
6.7.3 Nihon Kohden Corporation (Japan) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
6.7.4 Nihon Kohden Corporation (Japan) Business Overview
6.7.5 SWOT Analysis
6.8  F. Hoffmann-La Roche Ltd (Switzerland)
6.8.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Profile
6.8.2 Point-of-Care (POC) Coagulation Testing Product Overview
6.8.3 F. Hoffmann-La Roche Ltd (Switzerland) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
6.8.4 F. Hoffmann-La Roche Ltd (Switzerland) Business Overview
6.8.5 SWOT Analysis
6.9  Maccura Biotechnology Co. Ltd. (China)
6.9.1 Maccura Biotechnology Co. Ltd. (China) Company Profile
6.9.2 Point-of-Care (POC) Coagulation Testing Product Overview
6.9.3 Maccura Biotechnology Co. Ltd. (China) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
6.9.4 Maccura Biotechnology Co. Ltd. (China) Business Overview
6.9.5 SWOT Analysis
6.10  Bio Group Medical System (Italy)
6.10.1 Bio Group Medical System (Italy) Company Profile
6.10.2 Point-of-Care (POC) Coagulation Testing Product Overview
6.10.3 Bio Group Medical System (Italy) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
6.10.4 Bio Group Medical System (Italy) Business Overview
6.10.5 SWOT Analysis
6.11  Genrui Biotech Co. Ltd. (China)
6.11.1 Genrui Biotech Co. Ltd. (China) Company Profile
6.11.2 Point-of-Care (POC) Coagulation Testing Product Overview
6.11.3 Genrui Biotech Co. Ltd. (China) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
6.11.4 Genrui Biotech Co. Ltd. (China) Business Overview
6.11.5 SWOT Analysis
6.12  A&T Corporation (Japan)
6.12.1 A&T Corporation (Japan) Company Profile
6.12.2 Point-of-Care (POC) Coagulation Testing Product Overview
6.12.3 A&T Corporation (Japan) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
6.12.4 A&T Corporation (Japan) Business Overview
6.12.5 SWOT Analysis
6.13  Beijing Succeeder Technology Inc. (China)
6.13.1 Beijing Succeeder Technology Inc. (China) Company Profile
6.13.2 Point-of-Care (POC) Coagulation Testing Product Overview
6.13.3 Beijing Succeeder Technology Inc. (China) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
6.13.4 Beijing Succeeder Technology Inc. (China) Business Overview
6.13.5 SWOT Analysis
6.14  Diagnostica Stago SAS (France)
6.14.1 Diagnostica Stago SAS (France) Company Profile
6.14.2 Point-of-Care (POC) Coagulation Testing Product Overview
6.14.3 Diagnostica Stago SAS (France) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
6.14.4 Diagnostica Stago SAS (France) Business Overview
6.14.5 SWOT Analysis
6.15  Helena Laboratories Corporation (U.S.)
6.15.1 Helena Laboratories Corporation (U.S.) Company Profile
6.15.2 Point-of-Care (POC) Coagulation Testing Product Overview
6.15.3 Helena Laboratories Corporation (U.S.) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
6.15.4 Helena Laboratories Corporation (U.S.) Business Overview
6.15.5 SWOT Analysis
6.16  Hycel (Austria)
6.16.1 Hycel (Austria) Company Profile
6.16.2 Point-of-Care (POC) Coagulation Testing Product Overview
6.16.3 Hycel (Austria) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
6.16.4 Hycel (Austria) Business Overview
6.16.5 SWOT Analysis
7 Point-of-Care (POC) Coagulation Testing Business Cost Analysis
7.1 Labor Cost Analysis
7.2 Proportion of Manufacturing Cost Structure
7.3 Point-of-Care (POC) Coagulation Testing Industrial Chain Analysis
8 Point-of-Care (POC) Coagulation Testing Industry Dynamic Analysis
8.1 Point-of-Care (POC) Coagulation Testing Market Trends Analysis
8.2 Point-of-Care (POC) Coagulation Testing Market Drivers Analysis
8.3 Point-of-Care (POC) Coagulation Testing Market Challenges Analysis
8.4 Point-of-Care (POC) Coagulation Testing Market Restraints Analysis
9 Global Point-of-Care (POC) Coagulation Testing Forecast Market Analysis by Type & Application
9.1 Global Point-of-Care (POC) Coagulation Testing Revenue Market Forecast by Type (2023-2029)
9.2 Point-of-Care (POC) Coagulation Testing Revenue Market Forecast by Application (2023-2029)
10 Global Point-of-Care (POC) Coagulation Testing Forecast Market Analysis by Region
10.1 Point-of-Care (POC) Coagulation Testing Revenue Market Forecast by Region (2023-2029)
10.2 North America Point-of-Care (POC) Coagulation Testing Forecast Market Analysis
10.3 EMEA Point-of-Care (POC) Coagulation Testing Forecast Market Analysis
10.4 China Point-of-Care (POC) Coagulation Testing Forecast Market Analysis
10.5 Asia-Pacific Point-of-Care (POC) Coagulation Testing Forecast Market Analysis
10.6 Latin America Point-of-Care (POC) Coagulation Testing Forecast Market Analysis
11 Research Findings and Conclusion

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global and China Point-of-Care (POC) Coagulation Testing Industry Ecological Development and Analysis Report 2023

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?